About William Graff
Form D filings for Ostentus Therapeutics from 2021 to 2024 list William Graff as director and promoter.
William Graff first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name William Graff in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people William Graff works with at each company, as listed on that company's latest Form D.
Ostentus Therapeutics, Inc. · Form D, Mar 8, 2024
EG
Elisabetta Graff
President and director
SW
Stuart Weinstein
Director and promoter